Orlando, I understand that. But the market may assume there is a "loss of value" to GNBT because 10% of NIO is being spun off. Remember, the market is based on what it perceives is the value of the stock, not the actual value. Since the AE37 portion of GNBT has been valued at essentially 0 for the last 10 years or so, I agree that a rational market would not reduce the pps value of GNBT even if 100% of NIO was spun off. But since pps is perception of value, I strongly believe that the moment the divi is paid, there will be a perception of loss and the GNBT price will go down. I just hope that it will rebound quickly (ie, Joe puts out another positive PR about revenues or earnings!).
I do not expect a 1:1 loss of value ratio - ie, if the 10% of NIO shares has an estimated value of $20 million, GNBT will lose $20 million in market cap. But I do expect some adjustment - we'll just have to wait and see.
I am still wondering if NIO shares will be immediately traded on a US exchange as of 2/25 or not. If not, I have no idea how the GNBT BOD will value them - is it possible to get 1000 shares as a dividend, but have no pps applied to that dividend? That should actually be interesting, and I wonder how the brokerages will account for it.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links